Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone vs sufentanil for postoperative intravenous analgesia in moderate to severe OSA
ChiCTR2300077954Phase 4Not yet recruiting
- Sponsor
- The Eighth Affiliated Hospital of Sun Yat-sen University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxycodone in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by The Eighth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: NRS score. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2300077954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077954.